發(fā)布時(shí)間：2019-08-09 17:45

【摘要】：目的探討篩選自人卵巢癌細(xì)胞系HO8910干細(xì)胞的生物學(xué)特性。方法將前期篩選卵巢癌細(xì)胞系HO8910的干細(xì)胞在無(wú)血清培養(yǎng)基中進(jìn)行傳代培養(yǎng),以HO8910細(xì)胞作為對(duì)照。體外觀察兩種細(xì)胞的球體形成能力;將兩種細(xì)胞接種于含血清培養(yǎng)基,觀察其分化能力,并檢測(cè)干細(xì)胞相關(guān)標(biāo)記物;采用藥敏試驗(yàn)檢測(cè)兩種細(xì)胞對(duì)順鉑、多柔比星及米托蒽醌的敏感性;將無(wú)血清培養(yǎng)基中進(jìn)行傳代培養(yǎng)的兩種細(xì)胞接種于NOD/SCID裸鼠,觀察其體內(nèi)成瘤情況。結(jié)果 HO8910細(xì)胞在無(wú)血清培養(yǎng)基中的球體形成能力明顯低于卵巢癌細(xì)胞(P0.05)。卵巢癌干細(xì)胞分化前CD133、CD117陽(yáng)性表達(dá)率明顯高于分化后(P均0.05)。卵巢癌干細(xì)胞分化后ABCG2、Nanog、Oct4、BCRP、E-cadherin表達(dá)均低于分化前(P均0.05),與HO8910細(xì)胞分化前后上述指標(biāo)比較差異均無(wú)統(tǒng)計(jì)學(xué)意義(P均0.05)。0.25、0.5μg/m L順鉑,0.5、1.5μmol/L多柔比星,0.05、0.25μg/m L米托蒽醌作用于卵巢癌干細(xì)胞、HO8910細(xì)胞48 h時(shí),卵巢癌干細(xì)胞的相對(duì)活性均高于HO8910細(xì)胞(P均0.05)。裸鼠接種1×103個(gè)卵巢癌干細(xì)胞即可成瘤;隨著干細(xì)胞接種數(shù)量的增加,成瘤比率逐漸增加,成瘤時(shí)間逐漸縮短(P均0.05)。結(jié)論篩選自人卵巢癌細(xì)胞系HO8910的卵巢癌干細(xì)胞具有自我更新和分化、體內(nèi)成瘤、高表達(dá)干細(xì)胞基因以及對(duì)化療耐藥等特性,符合腫瘤干細(xì)胞的理論標(biāo)準(zhǔn)。
[Abstract]:Objective to investigate the biological characteristics of human ovarian cancer cell line HO8910. Methods the stem cells of ovarian cancer cell line HO8910 were subcultured in serum-free medium and HO8910 cells were used as control. The spherical formation ability of the two kinds of cells was observed in vitro, the differentiation ability of the two kinds of cells was observed, the differentiation ability was observed, and the related markers of stem cells were detected. The sensitivity of the two kinds of cells to DDP, doxorubicin and mitoxantrone was detected by drug sensitivity test. The two kinds of cells subcultured in serum-free medium were inoculated into NOD/SCID nude mice to observe their tumorigenesis in vivo. Results the globular formation ability of HO8910 cells in serum-free medium was significantly lower than that of ovarian cancer cells (P 0.05). The positive expression rate of CD133,CD117 in ovarian cancer stem cells before differentiation was significantly higher than that after differentiation. The expression of ABCG2,Nanog,Oct4,BCRP,E-cadherin in ovarian cancer stem cells after differentiation was lower than that before differentiation, but there was no significant difference compared with that before and after differentiation of HO8910 cells. 0.25 渭 g / mL DDP, 0.5 渭 mol / L doxorubicin, 0.05 渭 g / mL mitoxantrone and 0.25 渭 g / mL mitoxantrone on ovarian cancer stem cells for 48 h. The relative activity of ovarian cancer stem cells was higher than that of HO8910 cells. With the increase of the number of stem cells inoculated with 1 脳 103 ovarian cancer stem cells in nude mice, the tumorigenesis rate increased gradually and the tumorigenesis time decreased gradually (P 0.05). Conclusion the ovarian cancer stem cells screened from human ovarian cancer cell line HO8910 have the characteristics of self-renewal and differentiation, tumorigenesis in vivo, high expression of stem cell genes and resistance to chemotherapy, which is in accordance with the theoretical standard of tumor stem cells.
【作者單位】： 徐州醫(yī)學(xué)院;徐州醫(yī)學(xué)院附屬醫(yī)院;
【分類(lèi)號(hào)】：R737.31

【參考文獻(xiàn)】

相關(guān)期刊論文 前1條

1 閆洪超;于楠;仝建業(yè);陸曉媛;韓秋峪;魏敏;;人卵巢癌HO8910細(xì)胞株中干細(xì)胞的篩選及生物學(xué)特性鑒定[J];江蘇醫(yī)藥;2012年10期

【共引文獻(xiàn)】

相關(guān)期刊論文 前3條

1 陳曉杰;馮笑山;;紫杉醇與奈達(dá)鉑聯(lián)合化療方案不同給藥方式治療晚期卵巢癌的效果比較[J];河南醫(yī)學(xué)研究;2015年04期

2 仝建業(yè);閆洪超;;WWOX基因轉(zhuǎn)染對(duì)卵巢癌干細(xì)胞增殖的抑制作用及其機(jī)制探討[J];山東醫(yī)藥;2014年14期

3 蔣小芒;趙娜;龍敏;;卵巢癌細(xì)胞中CD90~+腫瘤干細(xì)胞的生物學(xué)特性[J];中國(guó)組織工程研究;2015年32期

相關(guān)博士學(xué)位論文 前1條

1 閆洪超;WWOX基因干預(yù)對(duì)人卵巢癌干細(xì)胞生物學(xué)行為的影響[D];山東大學(xué);2014年

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 秦薇,楊元先,王澤華;端粒酶活性與卵巢癌細(xì)胞系藥物敏感性的關(guān)系[J];腫瘤;2004年01期

2 劉琦,劉春敏,孟奎,姜少軍,吳波,石群立,任蘊(yùn)芳;膽酸鈉對(duì)人卵巢癌細(xì)胞系作用的研究[J];中國(guó)實(shí)用婦科與產(chǎn)科雜志;2004年11期

3 李曉艷;王澤華;;卵巢癌細(xì)胞系敏感株與耐藥株中環(huán)氧化酶-2的表達(dá)研究[J];中國(guó)婦幼保健;2006年05期

4 李力,陳心秋,黃薇,唐東平,黎丹戎;耐長(zhǎng)春新堿人卵巢癌細(xì)胞系的建立和耐藥機(jī)制的研究[J];廣西科學(xué);1998年01期

5 徐明娟,崔英,王昭梅,宋亮年;甾體激素對(duì)人卵巢癌細(xì)胞系3AO增殖分化的影響[J];上海醫(yī)學(xué);2001年02期

6 許沈華,牟瀚舟,呂桂泉,朱赤紅,羊正炎,高永良,樓洪坤,劉祥麟,程勇,楊文;高低轉(zhuǎn)移人卵巢癌細(xì)胞系基因表達(dá)譜差異(英文)[J];Chinese Medical Journal;2002年01期

7 白麗霞,趙麗嫣;脫氧氟尿苷逆轉(zhuǎn)人卵巢癌細(xì)胞系順鉑耐藥的研究[J];中國(guó)實(shí)用婦科與產(chǎn)科雜志;2003年04期

8 魏素菊,史健,劉義冰,馮威健;拓?fù)洚悩?gòu)酶Ⅰ、Ⅱ抑制劑序貫給藥對(duì)人卵巢癌細(xì)胞系的影響[J];實(shí)用腫瘤雜志;2005年02期

9 趙宏偉;田秀珠;張華屏;郭素堂;任連生;趙嘉惠;王波;;不同侵襲潛能卵巢癌細(xì)胞系蛋白質(zhì)譜的比較[J];基礎(chǔ)醫(yī)學(xué)與臨床;2006年06期

10 徐明娟,崔英,方國(guó)恩,宋亮年,王昭梅;糖皮質(zhì)激素對(duì)人卵巢癌細(xì)胞系(3AO)的誘導(dǎo)分化作用[J];上海醫(yī)學(xué);2003年04期

相關(guān)會(huì)議論文 前10條

1 鄭智國(guó);高，

本文編號(hào)：2524919